Gilead Sciences antiviral shows promise as new treatment
A new study conducted by scientists at the University of Texas Medical Branch suggests that the antiviral drug obeldesivir may be effective in treating Ebola Sudan infections, for which there are currently no approved vaccines or treatments. The drug, given in pill form, showed promising results in primate tests, with all treated animals surviving. If…